Literature DB >> 34374900

Antidepressant-like Effect of 3-n-Butylphthalide in Rats Exposed to Chronic Unpredictable Mild Stress: Modulation of Brain-Derived Neurotrophic Factor Level and mTOR Activation in Cortex.

Chunlin Chen1, Hao Ma2, Zhifeng Fu3.   

Abstract

3-n-Butylphthalide (NBP), an extract from seeds of Apium graveolens Linn. (Chinese celery), has been demonstrated to have antidepressant effects in suspension chronic-stressed rats by our group. The purpose of this study was to investigate the possible involvement of brain-derived neurotrophic factor (BDNF) and mammalian target of rapamycin (mTOR) in the antidepressant mechanism of NBP. Chronic unpredictable mild stress (CUMS) was applied for 6 weeks to induced a depressive-like behavior, characterized by decreased locomotor activity, sucrose preference and the NE, DA and 5-HT levels in cortex. Oral treatment with NBP (30 or 100 mg/kg, p.o.), similarly to fluoxetine (2 mg/kg, p.o.), can prevention of these alterations. The NBP (30 or 100 mg/kg, p.o.) reversed the decrease in the BDNF, p-ERK, mTOR and synapsin-1 protein levels in rat cortex caused by CUMS. And rapamycin, an mTOR inhibitor, completely inhibited the antidepressant-like activity of NBP in vivo. In conclusion, these findings indicate that NBP treatment attenuated the depression-like behaviors through the modulation of serotonergic system and BDNF-ERK-mTOR signaling in rat.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  3-n-Butylphthalide (NBP); BDNF; Depression; Rapamycin; mTOR

Mesh:

Substances:

Year:  2021        PMID: 34374900     DOI: 10.1007/s11064-021-03397-9

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  25 in total

Review 1.  A generalist's guide to treating patients with depression with an emphasis on using side effects to tailor antidepressant therapy.

Authors:  J Michael Bostwick
Journal:  Mayo Clin Proc       Date:  2010-04-29       Impact factor: 7.616

2.  The economic burden of adults with major depressive disorder in the United States (2005 and 2010).

Authors:  Paul E Greenberg; Andree-Anne Fournier; Tammy Sisitsky; Crystal T Pike; Ronald C Kessler
Journal:  J Clin Psychiatry       Date:  2015-02       Impact factor: 4.384

3.  DL-3-n-butylphthalide inhibits platelet activation via inhibition of cPLA2-mediated TXA2 synthesis and phosphodiesterase.

Authors:  Jianqin Ye; Lili Zhai; Shenghui Zhang; Yan Zhang; Leilei Chen; Liang Hu; Si Zhang; Zhongren Ding
Journal:  Platelets       Date:  2015-03-03       Impact factor: 3.862

Review 4.  Signaling pathways underlying the rapid antidepressant actions of ketamine.

Authors:  Ronald S Duman; Nanxin Li; Rong-Jian Liu; Vanja Duric; George Aghajanian
Journal:  Neuropharmacology       Date:  2011-09-02       Impact factor: 5.250

5.  Long-term treatment of l-3-n-butylphthalide attenuated neurodegenerative changes in aged rats.

Authors:  Shiping Ma; Shaofeng Xu; Bin Liu; Jiang Li; Nan Feng; Ling Wang; Xiaoliang Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-02-12       Impact factor: 3.000

Review 6.  Risk of QT/QTc prolongation among newer non-SSRI antidepressants.

Authors:  Natalia M Jasiak; Jolene R Bostwick
Journal:  Ann Pharmacother       Date:  2014-09-09       Impact factor: 3.154

7.  l-3-n-Butylphthalide ameliorates beta-amyloid-induced neuronal toxicity in cultured neuronal cells.

Authors:  Ying Peng; Changhong Xing; Cynthia A Lemere; Guiquan Chen; Ling Wang; Yipu Feng; Xiaoliang Wang
Journal:  Neurosci Lett       Date:  2008-02-14       Impact factor: 3.046

8.  Antiplatelet and antithrombotic activity of L-3-n-butylphthalide in rats.

Authors:  Ying Peng; Xianke Zeng; Yipu Feng; Xiaoliang Wang
Journal:  J Cardiovasc Pharmacol       Date:  2004-06       Impact factor: 3.105

9.  The novel targets of DL-3-n-butylphthalide predicted by similarity ensemble approach in combination with molecular docking study.

Authors:  Yan Wang; Wei Qi; Li Zhang; Zhenguang Ying; Ou Sha; Chunman Li; Lanhai Lü; Xiangyan Chen; Zhenzhong Li; Feng Niu; Fang Xue; Dong Wang; Tzi-Bun Ng; Lihong Zhang
Journal:  Quant Imaging Med Surg       Date:  2017-10

Review 10.  Brain-Derived Neurotrophic Factor, Depression, and Physical Activity: Making the Neuroplastic Connection.

Authors:  Cristy Phillips
Journal:  Neural Plast       Date:  2017-08-08       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.